Potentials and limitations of current and emerging immunotherapies

被引：1
|
作者：
Zettl, Uwe K. [1 ]
Mix, Eilhard [1 ]
机构：
[1] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany
来源：
JOURNAL OF NEUROLOGY | 2008年 / 255卷 / Suppl 6期
关键词：
Multiple Sclerosis; White Matter Lesion; Oligoclonal Band; Brospinal Fluid; Mesenchymal Stem Cell Transplantation;
D O I：
10.1007/s00415-008-6000-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [31] Cancer vaccines and immunotherapies: emerging perspectives
    Henderson, RA
    Mossman, S
    Nairn, N
    Cheever, MA
    VACCINE, 2005, 23 (17-18) : 2359 - 2362
  • [32] Efficacy and safety of emerging immunotherapies in psoriasis
    Yiu, Zenas Z. N.
    Warren, Richard B.
    IMMUNOTHERAPY, 2015, 7 (02) : 119 - 133
  • [33] Emerging Immunotargets and Immunotherapies in Prostate Cancer
    Montironi, Rodolfo
    Santoni, Matteo
    Sotte, Valeria
    Cheng, Liang
    Lopez-Beltran, Antonio
    Massari, Francesco
    Matrana, Marc R.
    Moch, Holger
    Berardi, Rossana
    Scarpelli, Marina
    CURRENT DRUG TARGETS, 2016, 17 (07) : 777 - 782
  • [34] LIFELONG LEARNING THROUGH SECOND LIFE: CURRENT TRENDS, POTENTIALS AND LIMITATIONS
    Goksel-Canbek, Nil
    Mavrommati, Maria
    Makridou-Bousiou, Despina
    Demiray, Ugur
    TURKISH ONLINE JOURNAL OF DISTANCE EDUCATION, 2011, 12 (03): : 154 - 163
  • [35] Classification of current anticancer immunotherapies
    Galluzzi, Lorenzo
    Vacchelli, Erika
    Bravo-San Pedro, Jose-Manuel
    Buque, Aitziber
    Senovilla, Laura
    Baracco, Elisa Elena
    Bloy, Norma
    Castoldi, Francesca
    Abastado, Jean-Pierre
    Agostinis, Patrizia
    Apte, Ron N.
    Aranda, Fernando
    Ayyoub, Maha
    Beckhove, Philipp
    Blay, Jean-Yves
    Bracci, Laura
    Caignard, Anne
    Castelli, Chiara
    Cavallo, Federica
    Celis, Estaban
    Cerundolo, Vincenzo
    Clayton, Aled
    Colombo, Mario P.
    Coussens, Lisa
    Dhodapkar, Madhav V.
    Eggermont, Alexander M.
    Fearon, Douglas T.
    Fridman, Wolf H.
    Fucikova, Jitka
    Gabrilovich, Dmitry I.
    Galon, Jerome
    Garg, Abhishek
    Ghiringhelli, Francois
    Giaccone, Giuseppe
    Gilboa, Eli
    Gnjatic, Sacha
    Hoos, Axel
    Hosmalin, Anne
    Jaeger, Dirk
    Kalinski, Pawel
    Kaerre, Klas
    Kepp, Oliver
    Kiessling, Rolf
    Kirkwood, John M.
    Klein, Eva
    Knuth, Alexander
    Lewis, Claire E.
    Liblau, Roland
    Lotze, Michael T.
    Lugli, Enrico
    ONCOTARGET, 2014, 5 (24) : 12472 - 12508
  • [36] Current status of immunotherapies for addiction
    Xu, Ashley
    Kosten, Thomas R.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2021, 1489 (01) : 3 - 16
  • [37] Current and emerging technologies for carbon accounting in urban landscapes: Advantages and limitations
    Habib, Salma
    Tahir, Furqan
    Hussain, Fabiha
    Macauley, Nadine
    Al-Ghamdi, Sami G.
    ECOLOGICAL INDICATORS, 2023, 154
  • [38] Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions
    Shohdy, Kyrillus S.
    Alfaar, Ahmad Samir
    THERAPEUTIC DELIVERY, 2013, 4 (09) : 1197 - 1209
  • [39] Current Immunotherapies for Glioblastoma Multiforme
    Huang, Boyuan
    Li, Xuesong
    Li, Yuntao
    Zhang, Jin
    Zong, Zhitao
    Zhang, Hongbo
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [40] Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
    Munir, Faryal
    He, Jiasen
    Connors, Jeremy
    Garcia, Miriam
    Gibson, Amber
    McCall, David
    Nunez, Cesar
    Dinh, Christine Nguyen
    Robusto, Lindsay
    Roth, Michael
    Khazal, Sajad
    Tewari, Priti
    Cuglievan, Branko
    TRANSLATIONAL PEDIATRICS, 2023, 12 (03) : 487 - 502
12345